From the Department of Rheumatology, University Hospital Zurich, Zurich, Switzerland.
L. Graf, cand.med., Department of Rheumatology, University Hospital Zurich; R. Dobrota, MD, Department of Rheumatology, University Hospital Zurich; S. Jordan, MD, Department of Rheumatology, University Hospital Zurich; L.M. Wildi, MD, Department of Rheumatology, University Hospital Zurich; O. Distler, MD, Department of Rheumatology, University Hospital Zurich; B. Maurer, MD, Department of Rheumatology, University Hospital Zurich.
J Rheumatol. 2018 Jan;45(1):103-106. doi: 10.3899/jrheum.170292. Epub 2017 Nov 1.
To investigate nodular regenerative hyperplasia (NRH) as a vascular complication of systemic sclerosis (SSc) with microvasculopathy as a common denominator.
Cases of SSc-NRH were identified by systematic literature review and by screening the Zurich cohort. NRH had to be diagnosed by liver biopsy.
Literature review retrieved 22 cases. In our cohort, 1.4% of patients with SSc were diagnosed with NRH. Most had vasculopathy, were positive for anticentromere antibodies, had elevated alkaline phosphatase and gamma-glutamyl transferase levels, normal liver morphology on ultrasound yet increased stiffness on ultrasound elastography, and had portal hypertension.
NRH might represent a rare yet potentially life-threatening vascular complication in SSc.
探讨结节性再生性增生(NRH)作为系统性硬化症(SSc)的血管并发症,其微血管病变为共同特征。
通过系统文献回顾和苏黎世队列筛查确定 SSc-NRH 病例。NRH 必须通过肝活检诊断。
文献回顾检索到 22 例。在我们的队列中,1.4%的 SSc 患者被诊断为 NRH。大多数患者存在血管病变,抗着丝点抗体阳性,碱性磷酸酶和γ-谷氨酰转移酶水平升高,超声检查肝脏形态正常,但超声弹性成像显示硬度增加,且存在门脉高压。
NRH 可能代表 SSc 中一种罕见但潜在危及生命的血管并发症。